{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:14:19Z","timestamp":1768990459419,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T00:00:00Z","timestamp":1679616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-023-03561-w","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T09:02:57Z","timestamp":1679648577000},"page":"2517-2526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic utility of serum and urine biomarkers in idiopathic membranous nephropathy: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"55","author":[{"given":"Dan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8693-6007","authenticated-orcid":false,"given":"Zhi-Guo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,24]]},"reference":[{"key":"3561_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.26442\/00403660.2020.06.000676","volume":"92","author":"IN Bobkova","year":"2020","unstructured":"Bobkova IN, Kamyshova ES (2020) Modern view on treatment of membranous nephropathy. Ter Arkh 92:99\u2013104. https:\/\/doi.org\/10.26442\/00403660.2020.06.000676","journal-title":"Ter Arkh"},{"key":"3561_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mayocp.2017.10.021","volume":"93","author":"JJ Sim","year":"2018","unstructured":"Sim JJ, Bhandari SK, Batech M et al (2018) End-stage renal disease and mortality outcomes across different glomerulonephropathies in a large diverse US population. Mayo Clin Proc 93:167\u2013178. https:\/\/doi.org\/10.1016\/j.mayocp.2017.10.021","journal-title":"Mayo Clin Proc"},{"key":"3561_CR3","first-page":"186","volume":"20","author":"I Rozenberg","year":"2018","unstructured":"Rozenberg I, Kotliroff A, Zahavi T et al (2018) Outcome of idiopathic membranous nephropathy: a retrospective study. Isr Med Assoc J 20:186\u2013189","journal-title":"Isr Med Assoc J"},{"key":"3561_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jfma.2014.11.002","volume":"114","author":"WL Lai","year":"2015","unstructured":"Lai WL, Yeh TH, Chen PM et al (2015) Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. J Formos Med Assoc 114:102\u201311. https:\/\/doi.org\/10.1016\/j.jfma.2014.11.002","journal-title":"J Formos Med Assoc"},{"key":"3561_CR5","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1681\/ASN.2016010093","volume":"27","author":"X Xu","year":"2016","unstructured":"Xu X, Wang G, Chen N et al (2016) Long-term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol 27:3739\u20133746. https:\/\/doi.org\/10.1681\/ASN.2016010093","journal-title":"J Am Soc Nephrol"},{"key":"3561_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/nep.12739","volume":"22","author":"L Tang","year":"2017","unstructured":"Tang L, Yao J, Kong X et al (2017) Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: a cross sectional study in China. Nephrology (Carlton) 22:168\u2013173. https:\/\/doi.org\/10.1111\/nep.12739","journal-title":"Nephrology (Carlton)"},{"key":"3561_CR7","doi-asserted-by":"publisher","first-page":"1900099","DOI":"10.1002\/gch2.201900099","volume":"4","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zheng S, Ma C et al (2020) Meta-analysis of the diagnostic efficiency of THSD7A-AB for the diagnosis of idiopathic membranous nephropathy. Glob Chall 4:1900099. https:\/\/doi.org\/10.1002\/gch2.201900099","journal-title":"Glob Chall"},{"key":"3561_CR8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.11817\/j.issn.1672-7347.2017.04.005","volume":"42","author":"X Wu","year":"2017","unstructured":"Wu X, Wen S, Zhu X et al (2017) Diagnostic value of renal phospholipase A2 receptor and serum anti-phospholipase A2 receptor antibody in membranous nephropathy. Zhong nan da xue xue bao Yi xue ban 42:395\u2013399. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2017.04.005","journal-title":"Zhong nan da xue xue bao Yi xue ban"},{"key":"3561_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/VHRM.S160883","volume":"14","author":"L Liu","year":"2018","unstructured":"Liu L, Chang B, Wu X et al (2018) Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy. Vasc Health Risk Manag 14:103\u2013108. https:\/\/doi.org\/10.2147\/VHRM.S160883","journal-title":"Vasc Health Risk Manag"},{"key":"3561_CR10","doi-asserted-by":"publisher","first-page":"3722","DOI":"10.1002\/pmic.201500127","volume":"15","author":"IM Rood","year":"2015","unstructured":"Rood IM, Merchant ML, Wilkey DW et al (2015) Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy. Proteomics 15:3722\u20133730. https:\/\/doi.org\/10.1002\/pmic.201500127","journal-title":"Proteomics"},{"key":"3561_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.5114\/aoms.2019.84690","volume":"15","author":"H Ma","year":"2019","unstructured":"Ma H, Xu Y, Zhang R et al (2019) Differential expression study of circular RNAs in exosomes from serum and urine in patients with idiopathic membranous nephropathy. Arch Med Sci 15:738\u2013753. https:\/\/doi.org\/10.5114\/aoms.2019.84690","journal-title":"Arch Med Sci"},{"key":"3561_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"key":"3561_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12011-016-0810-4","volume":"176","author":"M Xu","year":"2017","unstructured":"Xu M, Rui D, Yan Y et al (2017) Oxidative damage induced by arsenic in mice or rats: a systematic review and meta-analysis. Biol Trace Elem Res 176:154\u2013175. https:\/\/doi.org\/10.1007\/s12011-016-0810-4","journal-title":"Biol Trace Elem Res"},{"key":"3561_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12874-016-0189-0","volume":"16","author":"A Crippa","year":"2016","unstructured":"Crippa A, Orsini N (2016) Dose-response meta-analysis of differences in means. BMC Med Res Methodol 16:91. https:\/\/doi.org\/10.1186\/s12874-016-0189-0","journal-title":"BMC Med Res Methodol"},{"key":"3561_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa0810457","journal-title":"N Engl J Med"},{"key":"3561_CR16","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","volume":"26","author":"E Hoxha","year":"2011","unstructured":"Hoxha E, Harendza S, Zahner G et al (2011) An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26:2526\u20132532. https:\/\/doi.org\/10.1093\/ndt\/gfr247","journal-title":"Nephrol Dial Transplant"},{"key":"3561_CR17","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.2215\/CJN.02170312","volume":"7","author":"C Murtas","year":"2012","unstructured":"Murtas C, Bruschi M, Candiano G et al (2012) Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 7:1394\u20131400. https:\/\/doi.org\/10.2215\/CJN.02170312","journal-title":"Clin J Am Soc Nephrol"},{"key":"3561_CR18","doi-asserted-by":"publisher","first-page":"e61669","DOI":"10.1371\/journal.pone.0061669","volume":"8","author":"A Behnert","year":"2013","unstructured":"Behnert A, Fritzler MJ, Teng B et al (2013) An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor. PLoS One 8:e61669. https:\/\/doi.org\/10.1371\/journal.pone.0061669","journal-title":"PLoS One"},{"key":"3561_CR19","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","volume":"371","author":"NM Tomas","year":"2014","unstructured":"Tomas NM, Beck LH Jr, Meyer-Schwesinger C et al (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277\u20132287. https:\/\/doi.org\/10.1056\/NEJMoa1409354","journal-title":"N Engl J Med"},{"key":"3561_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1159\/000440983","volume":"42","author":"YG Kim","year":"2015","unstructured":"Kim YG, Choi YW, Kim SY et al (2015) Anti-phospholipase A2 receptor antibody as prognostic indicator in idiopathic membranous nephropathy. Am J Nephrol 42:250\u2013257. https:\/\/doi.org\/10.1159\/000440983","journal-title":"Am J Nephrol"},{"key":"3561_CR21","doi-asserted-by":"publisher","first-page":"1018\u20131022, 1028","DOI":"10.3969\/j.issn.1007-9572.2015.09.009","volume":"18","author":"X Yang","year":"2015","unstructured":"Yang X, Pan Y, Ding G (2015) Correlation of secreted phospholipase A2-I B, anti-phospholipase A2 receptor antibody with idiopathic membranous nephropathy among adult patients. Chinese General Practice 18:1018\u20131022, 1028. https:\/\/doi.org\/10.3969\/j.issn.1007-9572.2015.09.009","journal-title":"Chinese General Practice"},{"key":"3561_CR22","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.12659\/msm.896090","volume":"22","author":"X Li","year":"2016","unstructured":"Li X, Wei D, Zhou Z et al (2016) Anti-PLA2R antibodies in Chinese patients with membranous nephropathy. Med Sci Monit 22:1630\u20136. https:\/\/doi.org\/10.12659\/msm.896090","journal-title":"Med Sci Monit"},{"key":"3561_CR23","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.2215\/CJN.01460217","volume":"12","author":"J Wang","year":"2017","unstructured":"Wang J, Cui Z, Lu J et al (2017) Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol 12:1642\u20131651. https:\/\/doi.org\/10.2215\/CJN.01460217","journal-title":"Clin J Am Soc Nephrol"},{"key":"3561_CR24","doi-asserted-by":"publisher","first-page":"12049","DOI":"10.1038\/s41598-017-12014-1","volume":"7","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Huang B, Liu X et al (2017) Ultrasensitive quantitation of anti-phospholipase A2 receptor antibody as a diagnostic and prognostic indicator of idiopathic membranous nephropathy. Sci Rep 7:12049. https:\/\/doi.org\/10.1038\/s41598-017-12014-1","journal-title":"Sci Rep"},{"key":"3561_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40620-017-0451-5","volume":"31","author":"A Radice","year":"2018","unstructured":"Radice A, Pieruzzi F, Trezzi B et al (2018) Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. J Nephrol 31:271\u2013278. https:\/\/doi.org\/10.1007\/s40620-017-0451-5","journal-title":"J Nephrol"},{"key":"3561_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2018.12.027","volume":"490","author":"G Cheng","year":"2019","unstructured":"Cheng G, Liu J, Gilbert A et al (2019) Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: clinical value assessment. Clin Chim Acta 490:135\u2013141. https:\/\/doi.org\/10.1016\/j.cca.2018.12.027","journal-title":"Clin Chim Acta"},{"key":"3561_CR27","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.kint.2018.10.024","volume":"95","author":"C Zaghrini","year":"2019","unstructured":"Zaghrini C, Seitz-Polski B, Justino J et al (2019) Novel ELISA for thrombospondin type 1 domain-containing 7A autoantibodies in membranous nephropathy. Kidney Int 95:666\u2013679. https:\/\/doi.org\/10.1016\/j.kint.2018.10.024","journal-title":"Kidney Int"},{"key":"3561_CR28","first-page":"5959","volume":"13","author":"H Zhenzhen","year":"2020","unstructured":"Zhenzhen H, Yuan F, Wei C (2020) Effects of the expression of serum PLA2R antibody on the diagnosis and immunological therapy of idiopathic membranous nephropathy. Int J Clin Exp Med 13:5959\u20135966","journal-title":"Int J Clin Exp Med"},{"key":"3561_CR29","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3390\/biom10020319","volume":"10","author":"SM Maifata","year":"2020","unstructured":"Maifata SM, Hod R, Zakaria F et al (2020) Role of serum and urine biomarkers (PLA2R and THSD7A) in diagnosis, monitoring and prognostication of primary membranous glomerulonephritis. Biomolecules 10:319. https:\/\/doi.org\/10.3390\/biom10020319","journal-title":"Biomolecules"},{"key":"3561_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40620-014-0042-7","volume":"27","author":"SL Hu","year":"2014","unstructured":"Hu SL, Wang D, Gou WJ et al (2014) Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis. J Nephrol 27:111\u2013116. https:\/\/doi.org\/10.1007\/s40620-014-0042-7","journal-title":"J Nephrol"},{"key":"3561_CR31","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1681\/ASN.2019050538","volume":"31","author":"PD Burbelo","year":"2020","unstructured":"Burbelo PD, Joshi M, Chaturvedi A et al (2020) Detection of PLA2R autoantibodies before the diagnosis of membranous nephropathy. J Am Soc Nephrol 31:208\u2013217. https:\/\/doi.org\/10.1681\/ASN.2019050538","journal-title":"J Am Soc Nephrol"},{"key":"3561_CR32","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/0886022X.2018.1456457","volume":"40","author":"S Ren","year":"2018","unstructured":"Ren S, Wu C, Zhang Y et al (2018) An update on clinical significance of use of THSD7A in diagnosing idiopathic membranous nephropathy: a systematic review and meta-analysis of THSD7A in IMN. Ren Fail 40:306\u2013313. https:\/\/doi.org\/10.1080\/0886022X.2018.1456457","journal-title":"Ren Fail"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-023-03561-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-023-03561-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:10:21Z","timestamp":1694617821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-023-03561-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,24]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["3561"],"URL":"https:\/\/doi.org\/10.1007\/s11255-023-03561-w","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,24]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose. The authors have no competing interests to declare that are relevant to the content of this article. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. The authors have no financial or proprietary interests in any material discussed in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, ethical approval is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}